MedEquities Realty Trust Inc. (MRT)

11.03
NYSE : Finance
Prev Close 10.98
Day Low/High 10.96 / 11.11
52 Wk Low/High 6.27 / 11.85
Avg Volume 421.70K
Exchange NYSE
Shares Outstanding 31.84M
Market Cap 351.21M
EPS 0.20
Div & Yield N.A. (N.A)

Latest News

MedEquities Stockholders Approve Merger With Omega Healthcare Investors

MedEquities Stockholders Approve Merger With Omega Healthcare Investors

MedEquities Announces Payment Date Of May 15, 2019 For Conditional Dividend

WeissLaw LLP Files Class Action Lawsuit Against MedEquities Realty Trust, Inc.

WeissLaw LLP Files Class Action Lawsuit Against MedEquities Realty Trust, Inc.

NEW YORK, May 9, 2019 /PRNewswire/ -- WeissLaw LLP announced that it has filed a class action on behalf of shareholders of MedEquities Realty Trust, Inc.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABM, ACBI, INTL, KMI, MRT, THS Downgrades: COST, DCUD, HALL, OBSV Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Merger

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Merger

NEW YORK, Jan. 13, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: MINDBODY, Inc.

WEISSLAW LLP: MedEquities Realty Trust, Inc. Acquisition May Not Be In The Best Interests Of MRT Shareholders

WEISSLAW LLP: MedEquities Realty Trust, Inc. Acquisition May Not Be In The Best Interests Of MRT Shareholders

NEW YORK, Jan. 9, 2019 /PRNewswire/ --  WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of MedEquities Realty Trust, Inc.

MedEquities Realty Trust Reaches Analyst Target Price

MedEquities Realty Trust Reaches Analyst Target Price

In recent trading, shares of MedEquities Realty Trust Inc have crossed above the average analyst 12-month target price of $10.14, changing hands for $10.17/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of MedEquities Realty Trust, Inc.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of MedEquities Realty Trust, Inc.

NEW YORK, Jan. 2, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against MedEquities Realty Trust, Inc.

Omega Healthcare REIT to Buy MedEquities Trust for $600 Million

Omega Healthcare REIT to Buy MedEquities Trust for $600 Million

The cash-and-stock deal boosts Omega's portfolio of senior-assisted healthcare facilities; MedEquities shares surge.

MedEquities (MRT) Alert: Johnson Fistel Investigates Proposed Sale Of MedEquities Realty Trust; Are Shareholders Getting A Fair Deal?

MedEquities (MRT) Alert: Johnson Fistel Investigates Proposed Sale Of MedEquities Realty Trust; Are Shareholders Getting A Fair Deal?

SAN DIEGO, Jan. 2, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of MedEquities Realty Trust (NYSE: MRT) ("MedEquities") breached their fiduciary duties in connection with...

Omega Healthcare Investors To Acquire MedEquities Realty Trust

Omega Healthcare Investors To Acquire MedEquities Realty Trust

Omega Healthcare Investors, Inc. (NYSE: OHI) ("Omega") and MedEquities Realty Trust, Inc.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: EVK, IIPR, MFC, NTZ, SPLK Downgrades: AMBA, EA, EBR.B, GME, GROW, KNDI, MRT, QTRH, RDC, RMR, SOHO, SWKS, TDW Initiations: OPBK, YOGA Read on to get TheStreet Quant Ratings' detailed report:

Relative Strength Alert For MedEquities Realty Trust

Relative Strength Alert For MedEquities Realty Trust

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. MedEquities Realty Trust Inc presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

MedEquities Realty Trust Is Oversold

MedEquities Realty Trust Is Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. MedEquities Realty Trust Inc presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

RSI Alert: MedEquities Realty Trust Now Oversold

RSI Alert: MedEquities Realty Trust Now Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. MedEquities Realty Trust Inc presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

MRT Makes Bullish Cross Above Critical Moving Average

MRT Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of MedEquities Realty Trust Inc crossed above their 200 day moving average of $10.66, changing hands as high as $10.75 per share. MedEquities Realty Trust Inc shares are currently trading up about 2.5% on the day.

Ex-Div Reminder For MedEquities Realty Trust (MRT)

Ex-Div Reminder For MedEquities Realty Trust (MRT)

Looking at the universe of stocks we cover at Dividend Channel, on 8/14/18, MedEquities Realty Trust Inc will trade ex-dividend, for its quarterly dividend of $0.21, payable on 8/29/18. As a percentage of MRT's recent stock price of $10.07, this dividend works out to approximately 2.09%, so look for shares of MedEquities Realty Trust Inc to trade 2.09% lower — all else being equal — when MRT shares open for trading on 8/14/18.

Relative Strength Alert For MedEquities Realty Trust

Relative Strength Alert For MedEquities Realty Trust

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. MedEquities Realty Trust Inc presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

MRT Crosses Below Key Moving Average Level

MRT Crosses Below Key Moving Average Level

In trading on Wednesday, shares of MedEquities Realty Trust Inc crossed below their 200 day moving average of $10.76, changing hands as low as $10.08 per share. MedEquities Realty Trust Inc shares are currently trading down about 9.5% on the day.

MRT Crosses Above Average Analyst Target

MRT Crosses Above Average Analyst Target

In recent trading, shares of MedEquities Realty Trust Inc have crossed above the average analyst 12-month target price of $11.78, changing hands for $11.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

MedEquities Realty Trust (MRT) Shares Cross Above 200 DMA

MedEquities Realty Trust (MRT) Shares Cross Above 200 DMA

In trading on Tuesday, shares of MedEquities Realty Trust Inc crossed above their 200 day moving average of $10.83, changing hands as high as $10.93 per share. MedEquities Realty Trust Inc shares are currently trading up about 1.8% on the day.

Top Buys By Directors: Harlan's $262.5K Bet On MRT

Top Buys By Directors: Harlan's $262.5K Bet On MRT

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

Top Buys By Top Brass: COO Harlan's $262.5K Bet On MRT

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

TheStreet Quant Rating: C (Hold)